The Patent Finder

Neutrolis, Inc.

11 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Neutrolis Therapeutics, Inc. (to 2019)

0
Ending by 2030
Jan 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 12, 2027
    The maintenance fee for Engineering of Dnase Enzymes for Manufacturing and Therapy (US 11,840,712) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,464,833Methods for Treating or Preventing Tissue Adhesions
In force
 · High confidence
In forceHigh confidence
US 10,696,956Engineered Dnase Enzymes and Use in Therapy
In force
 · Medium confidence
In forceMedium confidence
US 10,801,019Engineered Dnase Enzymes and Use in Therapy
In force
 · Low confidence
In forceLow confidence
US 11,046,942Dnase Therapy for Intravascular Accumulation of Extracellular DNA
In force
 · Low confidence
In forceLow confidence
US 11,046,943Dnase Therapy for Intravascular Accumulation of Extracellular DNA
In force
 · Low confidence
In forceLow confidence
US 10,988,746Manufacturing and Engineering of Dnase Enzymes for Therapy
In force
 · Medium confidence
In forceMedium confidence
US 11,058,724Methods of Using DNASE1-LIKE 3 in Therapy
In force
 · Medium confidence
In forceMedium confidence
US 11,578,314Engineering of Dnase Enzymes for Manufacturing and Therapy
In force
 · Low confidence
In forceLow confidence
US 11,840,712Engineering of Dnase Enzymes for Manufacturing and Therapy
In force
 · Low confidence
In forceLow confidence
US 12,565,642Engineered Dnase Enzymes for Thrombosis Therapy
In force
 · Low confidence
In forceLow confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 6 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited